Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 75 years, of any sex
- People who have been diagnosed with a specific type of pancreatic cancer called pancreatic ductal adenocarcinoma (PDAC), confirmed through laboratory testing of tissue, and who have not yet received any treatment for it
- People from whom enough fresh tumour tissue can be collected through surgery or biopsy to grow laboratory models called organoids (tiny tumour replicas used for testing)
- People who are planned to receive chemotherapy — either as a single drug or a combination — before possible surgery, to try to make a tumour operable, or as a first treatment for cancer that has spread
- People who have at least one tumour that can be measured on a scan, according to standard measurement guidelines
- People who are reasonably physically well and able to carry out daily activities, based on a standard medical rating scale (ECOG score of 0, 1, or 2) (confirm with trial site)
- People with a life expectancy of at least 3 months
- People whose blood counts and organ function (including liver, kidneys, and bone marrow) meet the required health levels, as assessed through blood tests (confirm with trial site for specific values)
- People who are willing to give written consent to participate and are able to attend follow-up appointments as required
Who may not be able to join:
- People whose tumour tissue sample is not of sufficient quantity, quality, or condition to be used in the trial
- People whose tumour tissue sample would take more than 24 hours to reach the laboratory, including samples stored overnight before being sent
- People whose organoid (laboratory tumour model) fails to grow successfully, or whose test results do not meet quality standards
- People who are not able to tolerate chemotherapy treatment
- People with serious other health conditions, uncontrolled medical problems, or active infections
- People who are pregnant or breastfeeding
- People with a history of severe autoimmune disease (where the immune system attacks the body)
- People with any unstable health condition that could affect their safety or ability to participate in the trial
- People considered unsuitable for the trial by the supervising doctor
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0086-18917762352
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Concordance Between Organoid Drug Sensitivity Test Results and Clinical Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma Patients, Assessed by Sensitivity, Specificity, and Overall Accuracy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.